author-photo

Ayesha N. Shajahan-Haq

Georgetown University
Georgetown University Medical Center

58

Papers

652

Citations

Citation Trend

Filter By

Papers (46) Sort By

Journal Conference Others

Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer.

2021 Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer

2021 International Journal of Molecular Sciences
- Erin R. Scheidemann
- Ayesha N. Shajahan-Haq
Show All
- Source
- Cite
- Save
Citations (0)
Targeting WEE1 Inhibits Growth of Breast Cancer Cells That Are Resistant to Endocrine Therapy and CDK4/6 Inhibitors

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Mathematical modelling of breast cancer cells in response to endocrine therapy and Cdk4/6 inhibition

2020 Journal of the Royal Society Interface
Show All
- Source
- Cite
- Save
Citations (2)
Abstract P3-09-14: Regulation of gene expression and DNA methylation with cytotoxic T lymphocytes evaluation in subtypes of breast cancers

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P1-19-20: Safety of palbociclib in African American women with hormone receptor positive HER2 negative advanced breast cancer and benign ethnic neutropenia: PALINA study

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Glutamine metabolism drives growth in advanced hormone receptor positive breast cancer

2019 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (16)
The role of SLC7A5 (LAT1) in endocrine therapy resistant breast cancer

2019 bioRxiv
Show All
- Source
- Cite
- Save
Citations (4)
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study

2019 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (63)
SLCs contribute to endocrine resistance in breast cancer: Role of SLC7A5 (LAT1)

2019
Show All
- Source
- Cite
- Save
Citations (0)